Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Levofloxacin eye drops have obtained a drug registration certificate.
Xidian Pharmaceutical (301130.SZ) published an announcement that the company recently received a notice from the National Medical Products Administration (referred to as "").
Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) announced that the company recently received the drug registration certificate for levofloxacin eye drops issued by the National Medical Products Administration (referred to as the "NMPA").
Levofloxacin eye drops are used to treat infectious diseases caused by sensitive bacteria, such as blepharitis, meibomian gland inflammation, dacryocystitis, conjunctivitis, chalazion, keratitis, etc.
Related Articles
Bestechnic (Shanghai) Co., Ltd. (688608.SH) intends to collectively reduce its holdings by no more than 2% of the shares.
.png)
New Stock News | Jianbang High-Tech Plans to List in Hong Kong, China Securities Regulatory Commission Requires Supplementary Information on Chen Jian's Basic Information and Other Situations
On July 4th, KEEP (03650) spent HKD 464,000 to repurchase 100,000 shares.
Bestechnic (Shanghai) Co., Ltd. (688608.SH) intends to collectively reduce its holdings by no more than 2% of the shares.
New Stock News | Jianbang High-Tech Plans to List in Hong Kong, China Securities Regulatory Commission Requires Supplementary Information on Chen Jian's Basic Information and Other Situations
On July 4th, KEEP (03650) spent HKD 464,000 to repurchase 100,000 shares.
RECOMMEND
Anti-Overcompetition Drive Takes Hold Across Multiple Chinese Industries
04/07/2025
Bank of England Governor: Rise of Stablecoins May Undermine Confidence in National Currencies
04/07/2025
What the Passage of the “Big and Beautiful Act” Means for Americans: Gains and Losses Across Demographics
04/07/2025
